Ipca Laboratories has reported results for second quarter ended September 30, 2015.
The company has reported 80.93% fall its net profit at Rs 11.69 crore for the quarter ended September 30, 2015 as compared to Rs 61.3 crore for the same quarter in the previous year. The company’s total income has decreased by 4.41 % to Rs 754.48 crore for the quarter under review from Rs 789.31 crore for the corresponding quarter of the previous year.
Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.
